Robotic Minimally Invasive Ventral Hernia Repair With DEXTER
NCT ID: NCT07071740
Last Updated: 2026-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33 participants
OBSERVATIONAL
2025-06-11
2026-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robotic Minimally Invasive Inguinal Hernia Repair With Dexter
NCT05873582
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
NCT07181876
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
NCT04779918
Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair
NCT02684448
Versius or Laparoscopic TransAbdominal Inguinal Hernia REpair
NCT05262374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ventral hernia repair
Robotic-assisted incisional or primary ventral hernia repair with the DEXTER robotic surgery system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned to undergo incisional and primary midline ventral (M2-M4; epigastric, umbilical and infraumbilical) hernia repair smaller and equal to 8cm
* Patient agrees to perform the 30-day follow-up assessment, as per standard of care
Exclusion Criteria
* Active anticoagulant treatment
* Recurring hernia with mesh during primary hernia repair
* Need for transversal abdominal release
* Patients under corticosteroids or other immunosuppressive treatment
* Loss of domain type of hernia
* Previous incision extending from xiphoid process to pubic bone (= Median laparotomy M1 to M5)
* M2 hernia extending to M1 and/or M4 hernia extending to M5
* Ongoing intra-abdominal infection or septic state
* Abdominal fistulae
* History of major\* abdominal or pelvic surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Confinis
INDUSTRY
Distalmotion SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Allgemein öffentliches Krankenhaus Spittal/Drau
Spittal an der Drau, , Austria
GH Saintes - Saint-Jean-d'Angély Site de Saintes
Saintes, , France
Artemed Klinikum München Süd
München, , Germany
Kantonsspital Winterthur
Winterthur, , Switzerland
Hirslanden Klinik Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.